{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:54:24Z","timestamp":1790351664257,"version":"4.1.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00477","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T06:04:35Z","timestamp":1587449075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case Report of Complete Radiological Response of a Thalamic Glioblastoma After Treatment With Proton Therapy Followed by Temozolomide and Tumor-Treating Fields"],"prefix":"10.3389","volume":"10","author":[{"given":"Marco","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Dohmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"W\u00f6lk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Kolodziej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Acker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"B1","unstructured":"Central Nervous System Cancers [Online]2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2017.09.040","article-title":"Sequential proton boost after standard chemoradiation for high-grade glioma","volume":"125","author":"Adeberg","year":"2017","journal-title":"Radiother Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3892\/ol.2019.11110","article-title":"Complete radiological response following subtotal resection in three glioblastoma patients under treatment with tumor treating fields","volume":"19","author":"Kessler","year":"2020","journal-title":"Oncol Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11060-018-03057-z","article-title":"Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial","volume":"141","author":"Toms","year":"2019","journal-title":"J Neurooncol."},{"key":"B6","unstructured":"LouisDN\n            OhgakiH\n            WiestlerOD\n            CaveneeWK\n          17618441WHO Classification of Tumours of the Central Nervous System.2016"},{"key":"B7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.radonc.2015.12.003","article-title":"ESTRO-ACROP guideline \u201ctarget delineation of glioblastomas\u201d","volume":"118","author":"Niyazi","year":"2016","journal-title":"Radiother Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ijrobp.2015.11.042","article-title":"Improving tumor treating fields treatment efficacy in patients with glioblastoma using personalized array layouts","volume":"94","author":"Wenger","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-21293-3_7","article-title":"Investigating the connection between tumor treating fields distribution in the brain and glioblastoma patient outcomes: a simulation-based study utilizing a novel model creation technique","author":"Urman","year":"2019","journal-title":"SpringerOpen."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science."},{"key":"B12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"28421","DOI":"10.18632\/oncotarget.25420","article-title":"Comparative molecular characterization of typical and exceptional responders in glioblastoma","volume":"9","author":"Wipfler","year":"2018","journal-title":"Oncotarget."},{"key":"B14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.radonc.2018.11.025","article-title":"Cancer genetic markers according to radiotherapeutic response in patients with primary glioblastoma - radiogenomic approach for precision medicine","volume":"131","author":"Yang","year":"2019","journal-title":"Radiother Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fonc.2018.00451","article-title":"Molecular evolution of a glioblastoma controlled with tumor treating fields and concomitant temozolomide","volume":"8","author":"Robins","year":"2018","journal-title":"Front Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/nov010","article-title":"Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis","volume":"17","author":"Spiegl-Kreinecker","year":"2015","journal-title":"Neuro Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13148-019-0766-2","article-title":"The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care","volume":"11","author":"Karimi","year":"2019","journal-title":"Clin Epigenetics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3389\/fonc.2019.01288","article-title":"Corticosteroid-induced regression of glioblastoma: a radiographic conundrum","volume":"9","author":"Cuoco","year":"2019","journal-title":"Front Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fonc.2018.00440","article-title":"Proton vs. photon radiation therapy for primary gliomas: an analysis of the national cancer data base","volume":"8","author":"Jhaveri","year":"2018","journal-title":"Front Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/1471-2407-10-478","article-title":"Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial","volume":"10","author":"Combs","year":"2010","journal-title":"BMC Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmri.26306","article-title":"Perfusion MRI in treatment evaluation of glioblastomas: clinical relevance of current and future techniques","volume":"49","author":"van Dijken","year":"2019","journal-title":"J Magn Reson Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z","article-title":"Microvessel density is a prognostic indicator for patients with astroglial brain tumors","volume":"77","author":"Leon","year":"1996","journal-title":"Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3171\/2013.10.JNS13103","article-title":"Clinical application of perfusion computed tomography in neurosurgery","volume":"120","author":"Huang","year":"2014","journal-title":"J Neurosurg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/neuonc\/noy075","article-title":"Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC","volume":"20","author":"Cloughesy","year":"2018","journal-title":"Neuro Oncol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00477\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T06:04:38Z","timestamp":1587449078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00477\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":25,"alternative-id":["10.3389\/fonc.2020.00477"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00477","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"article-number":"477"}}